Neuro-oncology

ANGIOGENESIS AND INVASION.

Neuro-oncology

Y.-L. Hu, M. De Lay, S. D. Rose, W. S. Carbonell, M. K. Aghi, S. D. Rose, W. S. Carbonell, M. De Lay, Y.-L. Hu, J. Paquette, T. Tokuyasu, S. Tsao, M. Chaumeil, S. Ronen, M. K. Aghi, L. A. Matlaf, L. Soroceanu, C. Cobbs, L. Soroceanu, L. Matlaf, L. Harkins, C. Cobbs, T. Garzon-Muvdi, C. a. Rhys, C. Smith, D.-H. Kim, L. Kone, H. Farber, S. An, A. Levchenko, A. Quinones-Hinojosa, D. Lemke, P.-N. Pfenning, F. Sahm, A.-C. Klein, T. Kempf, M. Schnolzer, M. Platten, W. Wick, S. J. Smith, R. Rahman, C. Rahman, J. Barrow, D. Macarthur, F. Rose, R. G. Grundy, T. J. Kaley, J. Huse, S. Karimi, M. Rosenblum, A. Omuro, L. M. DeAngelis, J. F. de Groot, L.-Y. Kong, J. Wei, T. Wang, Y. Piao, J. Liang, G. N. Fuller, W. Qiao, A. B. Heimberger, N. Jhaveri, H. Cho, S. Torres, W. Wang, A. Schonthal, N. Petasis, S. G. Louie, F. Hofman, T. C. Chen, R. Yamada, S. Sumual, V. Buljan, M. R. Bennett, K. L. McDonald, M. Weiler, P.-N. Pfenning, A.-L. Thiepold, L. Jestaedt, J. Gronych, L. M. Dittmann, M. Jugold, M. Kosch, S. E. Combs, A. von Deimling, M. Weller, M. Bendszus, M. Platten, W. Wick, A. Kwiatkowska, V. Paulino, N. L. Tran, M. Symons, A. L. Stockham, E. Borden, D. Peereboom, Y. Hu, A. Chaturbedi, M. Hamamura, E. Mark, Y.-H. Zhou, S. Abbadi, H. Guerrero-Cazares, F. Pistollato, C. L. Smith, W. Ruff, A. D. Puppa, G. Basso, A. Quinones-Hinojosa, M. Monje, M. E. Freret, M. Masek, P. G. Fisher, T. Haddix, H. Vogel, N. Kijima, N. Hosen, N. Kagawa, N. Hashimoto, Y. Fujimoto, M. Kinoshita, H. Sugiyama, T. Yoshimine, N. Anneke, H. Bob, W. Pieter, H. Arend, L. William, M. Eoli, A. Calleri, L. Cuppini, E. Anghileri, S. Pellegatta, E. Prodi, M. G. Bruzzone, F. Bertolini, G. Finocchiaro, D. Zhu, S. B. Hunter, P. M. Vertino, E. G. Van Meir, S. M. Cork, B. Kaur, L. Cooper, J. H. Saltz, E. M. Sandberg, E. G. Van Meir, K. Burrell, R. Hill, G. Zadeh, J. J. Parker, K. Dionne, R. Massarwa, M. Klaassen, L. Niswander, B. K. Kleinschmidt-DeMasters, A. Waziri, S. Jalali, T. Wataya, F. Salehi, S. Croul, F. Gentili, G. Zadeh, S. Jalali, W. Foltz, K. Burrell, J.-I. Lee, S. Agnihorti, C. Menard, C. Chung, G. Zadeh, S. Torres, N. Jhaveri, W. Wang, A. H. Schonthal, S. G. Louie, F. M. Hofman, T. C. Chen, P. Elena, G. Faivre, A. Demopoulos, S. Taillibert, M. Rosenblum, A. Omuro, M. Kirsch, K. D. Martin, A. Bertram, O. uckermann, E. Leipnitz, P. Weigel, A. Temme, G. Schackert, K. Geiger, E. Gerstner, D. Jennings, A. S. Chi, S. Plotkin, S. J. Kwon, M. Pinho, P. Polaskova, T. T. Batchelor, A. G. Sorensen, M. B. Hossain, A. E. Gururaj, N. Cortes-Santiago, K. Gabrusiewicz, W. K. A. Yung, J. Fueyo, C. Gomez-Manzano, O. D. Gil, S. Noticewala, S. Ivkovic, M. Esencay, D. Zagzagg, S. Rosenfeld, J. N. Bruce, P. Canoll, J. H. Chang, H. J. Seol, A. Weeks, C. A. Smith, J. T. Rutka, J. Georges, G. Samuelson, A. Misra, A. Joy, Y. Huang, M. McQuilkin, A. Yoshihiro, D. Carpenter, L. Butler, B. Feuerstein, S. F. Murphy, T. Vaghaiwalla, M. Wotoczek-Obadia, R. Albright, D. Mack, S. Lawn, F. Henderson, M. Jung, S. Dakshanamurthy, M. Brown, P. Forsyth, S. Brem, M. S. Sadr, D. Maret, E. S. Sadr, V. Siu, J. Alshami, G. Trinh, J.-S. Denault, D. Faury, N. Jabado, A. Nantel, R. Del Maestro

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

Neuro-oncology

Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

Neuro-oncology

Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD

DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.

Neuro-oncology

Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Chang SM, Prados MD, Tihan T, Vandenberg SR, Kelsey KT, Berger MS, Wiencke JK

DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.

Neuro-oncology

Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Chang SM, Prados MD, Tihan T, Vandenberg SR, Kelsey KT, Berger MS, Wiencke JK

Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.

Neuro-oncology

Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA

Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.

Neuro-oncology

Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Neuro-oncology

Srinivasan R, Phillips JJ, Vandenberg SR, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Neuro-oncology

Srinivasan R, Phillips JJ, Vandenberg SR, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

Neuro-oncology

Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, Aghi M, Jacques A, Murray D, Sabri S, Abdulkarim B

Pages